Cargando…
Clotrimazole for Vulvovaginal Candidosis: More Than 45 Years of Clinical Experience
Vulvovaginal candidosis is a common disease, and various treatment strategies have emerged over the last few decades. Clotrimazole belongs to the drugs of choice for the treatment of vulvovaginal candidosis. Although available for almost 50 years, systematic reviews on the usefulness of topical clot...
Autores principales: | Mendling, Werner, Atef El Shazly, Maged, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600851/ https://www.ncbi.nlm.nih.gov/pubmed/32992877 http://dx.doi.org/10.3390/ph13100274 |
Ejemplares similares
-
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)
por: Farr, Alex, et al.
Publicado: (2021) -
Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion
por: Donders, Gilbert, et al.
Publicado: (2022) -
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
por: Sustr, Valentina, et al.
Publicado: (2020) -
Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome
por: Oerlemans, Eline F. M., et al.
Publicado: (2020) -
Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review
por: Disha, Tasfia, et al.
Publicado: (2022)